Author: Kanagalingam, J.; Feliciano, R.; Hah, J. H.; Labib, H.; Le, T. A.; Lin, J.-C.
Title: Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections Document date: 2015_8_6
ID: jiblk5qp_38
Snippet: The efficacy of PVP-I as an anti-oedematous agent was also evident in a randomised controlled clinical trial of 30 patients undergoing mandibular third molar removal (split mouth design) (99) On assessing the postoperative effect of PVP-I (0.5 mg/ml) when used as an irrigant and coolant, a significant decrease in swelling and trismus was observed compared with saline control (p = 0.001). No significant difference was observed in pain scores betwe.....
Document: The efficacy of PVP-I as an anti-oedematous agent was also evident in a randomised controlled clinical trial of 30 patients undergoing mandibular third molar removal (split mouth design) (99) On assessing the postoperative effect of PVP-I (0.5 mg/ml) when used as an irrigant and coolant, a significant decrease in swelling and trismus was observed compared with saline control (p = 0.001). No significant difference was observed in pain scores between the treatment groups (99) . Similar observations were reported in another study in which the reduced postoperative swelling by PVP-I was attributed to the inhibitory effect on leukotriene B4 and leucocyte extravasation (98) .
Search related documents:
Co phrase search for related documents- clinical trial and mouth design: 1
- clinical trial and pain score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- clinical trial and postoperative effect: 1, 2, 3, 4, 5, 6, 7
- clinical trial and PVP efficacy: 1, 2
- clinical trial and saline control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical trial and significant decrease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- clinical trial and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical trial and split mouth design: 1
- clinical trial and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical trial and trismus swelling: 1
- inhibitory effect and PVP efficacy: 1
- inhibitory effect and saline control: 1, 2
- inhibitory effect and significant decrease: 1, 2
- inhibitory effect and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9
- inhibitory effect and similar observation: 1
- inhibitory effect and treatment group: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date